Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5076 Target Snapshot

Histamine H3 receptor · SINGLE PROTEIN · Cavia porcellus

686Compounds
129Assays
4Approved Drugs
686.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9JI35. Use UniProt Q9JI35 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9JI35 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histamine H3 receptor as ChEMBL target CHEMBL5076, mapped to UniProt Q9JI35. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histamine H3 receptor
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-13
ChEMBL target ID
CHEMBL5076
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9JI35
Histamine H3 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histamine H3 receptor is the right protein anchor across sources, using UniProt Q9JI35 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistamine H3 receptor
UniProt AccessionQ9JI35
Component TypeProtein
Sequence Length445 aa

Histamine H3 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histamine H3 receptor, mapped to UniProt Q9JI35. Sequence length is 445 aa.

Mapped IDQ9JI35
Review nameHistamine H3 receptor
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

4
Approved
2
Phase II
Assay Mix

Activity Type Distribution

IC5015.0
KI348.0
EC501.0
KD322.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL371730 10.1 Kd 0.07943 Preclinical
CHEMBL268229 10.07 Ki 0.08511 Preclinical
CHEMBL200382 9.9 Kd 0.1259 Preclinical
CHEMBL90 9.84 Ki 0.1445 Approved
CHEMBL1222863 9.82 Ki 0.15 Preclinical
CHEMBL14690 9.8 Kd 0.1585 Preclinical
CHEMBL373000 9.8 Kd 0.1585 Preclinical
CHEMBL462605 9.8 Ki 0.16 Approved
CHEMBL1222800 9.7 Ki 0.2 Preclinical
CHEMBL1222865 9.7 Kd 0.1995 Preclinical
Distribution

pChEMBL Value Distribution

10
5.0
21
5.5
37
6.0
64
6.5
126
7.0
159
7.5
128
8.0
76
8.5
26
9.0
16
9.5
pChEMBL
Approved Drugs

Approved Drugs

PITOLISANT
CHEMBL462605
Approved 2016
HISTAMINE
CHEMBL90
Approved 1939
Assay Landscape

Assay Landscape

129
Total Assays
432
Tested Compounds
2
Assay Types
Functional — 69 assays, 202 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 55 195 7.5
assay format 10 6 7.0
cell-based format 2 1 9.3
organism-based format 2 0
Binding — 60 assays, 432 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 33 177 7.7
assay format 13 151 7.8
single protein format 11 74 7.7
cell membrane format 3 30 7.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine